Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Dr. Ivan Keituqwa Yañez
Dr. Silvestre Nicolas-Franco
Echocardiography has turned out to be a tool par excellence for diagnosis and decision making in the management of mitral regurgitation. The aim of echocardiographic evaluation should include quantification of mitral valve regurgitation, analysing the mechanisms involved, as well as assessing the consequences on the function and geometry of the left ventricle (LV). Echocardiography is the imaging technique of choice in the follow-up of patients with mitral regurgitation who have undergone therapeutic interventions, both to assess the success of these and to evaluate their impact on the geometry and function of the LV.
Mitral regurgitation (MR) is the most frequent clinically recognisable valvular heart disease in the western world . MR can be caused by primary valve anatomical disorders (primary MR) or it can be secondary to cardiomyopathy (secondary MR, previously referred to as functional MR).
The pathophysiological key problem of MR is the magnitude of the regurgitation volume. Left ventricle (LV) response to this chronic volume overload is characterised by changes in LV structure and geometry as compensatory adaptation. Later, this compensatory mechanism is overwhelmed, leading to LV dysfunction.
Echocardiography is the main tool for assessing the severity and mechanism of the MR and its consequences on the LV as well as being a clinical standard for the evaluation of the mitral apparatus.
The present paper evaluates the echocardiographic parameters of LV remodelling in MR as well as the impact on them of surgical and endovascular interventions, such as cardiac resynchronisation therapy (CRT) and percutaneous endovascular mitral valve repair.
LV remodelling is a complex and progressive set of structural and functional changes at the cellular and interstitial level which occur following volume and/or pressure overload and myocardial injury.
In MR, part of the stroke volume does not contribute to the peripheral circulation and therefore does not contribute to the cardiac output. The volume overload exerted on the LV due to mitral incompetence results in elevated stress on the LV walls during diastole. In response, LV compensates for it by eccentric hypertrophy and remodelling. At a molecular and cellular level, there is an increase in the length of the myocardial fibres with a disorganisation and remodelling of the extracellular matrix, resulting in a realignment of the myocardial fibres that leads to development of LV geometry abnormalities . These changes in the LV geometry can be detected in the echocardiographic study:
In the compensated stage of eccentric hypertrophy secondary to MR, the LV ejection fraction (LVEF) remains normal or increased, and the relative wall thickness (RWT) also remains normal. Because in eccentric hypertrophy the radius of the LV is increased, it requires an increase in the absolute thickness of the LV wall in order to maintain normal wall tension, i.e., to keep the relationship between radius and LV wall thickness normal. RWT typically remains ≤0.42.
The normal ellipsoidal shape of the LV in chronic mitral valve diseases is altered, becoming more spherical. This is detected in an echocardiographic study by measuring the sphericity index (calculated as LV short-to-long axis dimension ratio at end diastole in the apical four-chamber view), with a cut-off value of 0.7.
The shape of the LV is closely associated with the LVEF. When the geometrical alterations originating in an LV with eccentric hypertrophy secondary to chronic volume overload lead to loss in the normal orientation of the cardiomyocytes, LVEF finally decreases .
The changes in LV geometry secondary to remodelling, whether the cause is ischaemic heart disease (IHD) or dilated cardiomyopathy (DCM), lead to a disruption in the normal relationships between the LV and the mitral apparatus. Secondary mitral regurgitation (SMR) entails not an affectation of the mitral valve per se, but a remodelling and an alteration of the normal geometry of the LV. This leads to a disruption of the normal spatial relationships of the valve apparatus and generates an imbalance between the closing and tethering forces .
Here echocardiography plays a crucial role not only in the diagnosis of the aetiology and determination of the degree of severity of the MR but also in the characterisation of LV remodelling when it comes to choosing an appropriate therapeutic approach. An echocardiography study must distinguish between functional MR produced by global ventricular dilation and that caused by localised abnormalities, and the effects of altered ventricular geometry on MR need to be specifically addressed.
In IHD, an inferolateral scar and associated local remodelling distort the normal geometry of the LV and displace the posteromedial papillary muscle posteriorly and apically, producing an imbalance between closure forces and tethering forces that reduces the MV leaflet coaptation . In this case, the displacement of papillary muscles is asymmetrical, resulting in a malapposition of the leaflets with an eccentric, posteriorly directed jet of MR.
In DCM, both papillary muscles are displaced symmetrically posteriorly and apically pushing to an apical displacement of the coaptation line. As the displacement of both leaflets is symmetrical, the regurgitant jet is central.
LV reverse remodelling is associated with improved morbidity and mortality. The concept of reverse remodelling was introduced in the 1990s by Kass  and describes the regression of hypertrophy, size, shape and function of the LV. Both types of LV remodelling described above, the one caused by chronic volume overload in the primary valve lesion or the initial ventricular remodelling responsible for secondary MR, can be reversed after different types of therapeutic intervention.
Echocardiography is the imaging technique of choice in the follow-up of patients with MR who have undergone therapeutic interventions, both to assess the success of these and to evaluate their impact on the geometry and function of the LV.
Optimal medical treatment is the first line of treatment in MR and its use is recommended by the ESC guidelines . In patients with secondary MR, medical treatment of the myocardiopathy from which it originates (DCM or IHD) is the most widely extended initial treatment. The effects of beta-blocker therapy in LV geometry in patients with heart failure (HF) with reduced ejection fraction have been widely studied. The beneficial effect of beta-blocker therapy on LV remodelling reversal has been linked to a decrease of LV volumes , a decrease in the LVM index [8,9] and an improvement of LV geometry as evidenced by a decrease of the sphericity index . Long-term angiotensin-converting enzyme inhibition, angiotensin receptor blockade and aldosterone receptor antagonism affect LV remodelling through reducing the loading conditions and cardiac afterload, resulting in an improvement in LVM and LV geometry.
Cardiac resynchronisation therapy (CRT) is a well-established recommended therapy for patients with HF, depressed LVEF and intraventricular conduction disturbance. In responders, CRT may immediately reduce MR severity through increased closing force and resynchronisation of papillary muscles , which is directly related to the electric cardiac stimulation. Following CRT, there is less LV volume overload which, in addition to the increased LV contraction efficiency, participates in the restoration of the LV size. Echocardiographic follow-up of patients with DCM or IHD and MR treated with CRT is not only useful to confirm the reduction of the severity of it in responders, but also to assess the improvement of LV volumes .
The current ESC guidelines for the management of valvular heart disease recommend a surgical strategy for symptomatic patients and asymptomatic patients presenting with chronic primary MR and LVESD ≥45 mm, placing emphasis on the worse postoperative outcome of patients with LVESD of 40-44 mm compared to those with LVESD less than 40 mm . After surgical intervention (both mitral valve repair and valve replacement), symptom and cardiac function improvement occur rapidly. Echocardiography is the most important imaging tool for assessing LV reverse remodelling by documenting the decrease in LV volumes that usually occurs between four and six months after the surgery .
After a successful percutaneous edge-to-edge mitral valve repair, MR severity and loading conditions decrease. The LV unload can explain the rapid decrease in LVEDV already seen 24 hours after the intervention . After 12 months, further favourable changes are seen in the echocardiography follow-up consistent with a greater reduction in LVEDV and decreases in LVESV and LV mass .
Left ventricular remodelling may be the consequence of chronic volume overload in the case of primary MR or the cause of valvular insufficiency in the case of an LV with a distorted geometry resulting from IHD or DCM. Echocardiography is an invaluable tool able to differentiate between both aetiologies of MR (primary or secondary) and characterise the remodelling of the LV as well as reverse remodelling secondary to therapeutic interventions.
Ivan Keituqwa Yañez1, MD; Silvestre Nicolas-Franco2, MD, PhD
Address for correspondence:
Ivan Keituqwa Yañez, C/ Martin Morata, Nº4, 4º D, 30800 Lorca (Murcia), Spain.
Tel: +34 606408350; +34 968428039
The authors have no conflicts of interest to declare.
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.